» Articles » PMID: 39133623

Bleeding Recurrence Risk Among Hospitalized Patients Undergoing Therapeutic Plasma Exchange: a Multi-center Study

Overview
Journal Blood Transfus
Specialty Hematology
Date 2024 Aug 12
PMID 39133623
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In hospitalized patients undergoing therapeutic plasma exchange (TPE), it is not known how TPE-associated bleeding risk is impacted by a prior bleeding episode. Therefore, to assess the prevalence and predictors of bleeding recurrence, we analyzed data from the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Materials And Methods: Using a retrospective cross-sectional analysis of REDS-III public use files, we identified hospitalized adults who had a major bleeding episode prior to their first TPE procedure. Patients were classified into two cohorts based on bleeding recurrence (no-recurrence vs recurrence). After identifying potential predictors, we used multiple imputation by chained equations to impute variables with <30% missing data. Variable selection was optimized using a 10-fold cross validated least absolute shrinkage and selection operator. Final predictors were identified by fitting a logistic regression model.

Results: In 310 patients with major bleeding prior to TPE initiation, bleeding recurred in 121 (39.0%). We identified the following seven unique predictors: 1) >10 TPE procedures (OR 2.23); 2) intensive care unit stay (OR 1.35); 3) thrombocytopenia (OR 1.26); 4) surgery (OR 1.22); 5) hepatic disease (OR 1.21); 6) 6-10 TPE procedures (OR 1.04); and 7) Asian race (OR 1.01). We also identified the following five interactions: 1) surgery and therapeutic anticoagulation (OR 1.50); 2) 6-10 TPE procedures and therapeutic anticoagulation (OR 1.05); 3) 6-10 TPE procedures and antiplatelets (OR 1.02); 4) >10 TPE procedures and antiplatelets (OR 1.00); and 5) albumin-only TPE and antiplatelets (OR 0.53). When assessed for adjusted performance, the prediction model had a C-statistic of 0.617 (95% CI 0.613-0.619) and Brier Score of 0.342 (95% CI 0.340-0.347).

Discussion: In this study assessing predictors of bleeding recurrence among hospitalized patients undergoing TPE, we identified seven variables and five interactions. These findings should be validated in future studies.

Citing Articles

Developing A Model to Predict Major Bleeding Among Hospitalized Patients Undergoing Therapeutic Plasma Exchange.

Soares Ferreira Junior A, Lessa M, Sanborn K, Gordee A, Kuchibhatla M, Karafin M J Clin Apher. 2025; 40(2):e70013.

PMID: 40045567 PMC: 11893082. DOI: 10.1002/jca.70013.


How Protein Depletion Balances Thrombosis and Bleeding Risk in the Context of Platelet's Activatory and Negative Signaling.

Montecino-Garrido H, Trostchansky A, Espinosa-Parrilla Y, Palomo I, Fuentes E Int J Mol Sci. 2024; 25(18).

PMID: 39337488 PMC: 11432290. DOI: 10.3390/ijms251810000.

References
1.
Singh M . Approach to the Coagulopathic Patient in the Intensive Care Unit. Indian J Crit Care Med. 2019; 23(Suppl 3):S215-S220. PMC: 6785821. DOI: 10.5005/jp-journals-10071-23256. View

2.
Gage B, Yan Y, E Milligan P, Waterman A, Culverhouse R, Rich M . Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006; 151(3):713-9. DOI: 10.1016/j.ahj.2005.04.017. View

3.
Ow T, Fatourou E, Rabinowich L, van den Boom B, Nair S, Patel V . Prevalence of Bleeding and Thrombosis in Critically Ill Patients with Chronic Liver Disease. Thromb Haemost. 2021; 122(6):1006-1016. DOI: 10.1055/a-1667-7293. View

4.
OBrien E, Simon D, Thomas L, Hylek E, Gersh B, Ansell J . The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J. 2015; 36(46):3258-64. PMC: 4670965. DOI: 10.1093/eurheartj/ehv476. View

5.
Onuoha C, Barton K, Wong E, Raval J, Rollins-Raval M, Ipe T . Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: A systematic review. Transfusion. 2020; 60(11):2714-2736. DOI: 10.1111/trf.16018. View